Heme Flashcards
1
Q
proper administration of iron supplements
A
- give in divided doses for max absorption
- give in b/w meals to inc absorption
- administer w/ fruit juice or multivitamin preparation
- vit C facilitates absorption
- do not administer w/ milk or antacids–dec absorption
- do not give w/ tea–b/c tannin in tea binds iron to form an insoluble complex
- may stain teeth–administer to infants via a syringe, older children via a straw
- wash off teeth after administration
- only keep a month supply in the home b/c it is a poison
2
Q
therapeutic mgmt to prevent iron deficiency anemia
A
- breast milk or commercial formula should be used for the first 12 mos of life
- begin iron supplements
- full term: by 4-6 mos via iron fortified formula or rice cereal
- preterm: by 2 mos via iron drops initially, then iron fortified cereal
- administer ferrous sulfate at 2-3 mg/kg to breast fed preterm infants after 2 mos
- limit amt of milk to <1 L/day
- universal screening for iron deficiency starts at 12 mos
3
Q
causes of anemia
A
- bone marrow fails to produce RBCs
- leukemia or other malignancy
- chronic renal dz
- collagen dz
- hypothyroidism
4
Q
aplastic anemia
A
- all formed elements in the blood are depressed
- pancytopenia–low platelets (so dec clotting), WBC (so dec ability to fight infection), low RBC (so dec O2 carry capacity)
5
Q
hypoplastic anemia
A
- profound depression of RBCs, but normal WBCs and platelet
- this is how iron deficiency anemia works
6
Q
Sickle Cell Anemia
A
- hereditary hemoglobinopathy
- ethnicity:
- primarily in African Americans
- occasionally in ppl of Mediterranean descent
- also seen in South American, Arabian, and East Indian descent
7
Q
etiology of Sickle Cell
A
- in areas where malaria is common, individuals w/ sickle cell trait tend to have a survival advantage over those w/o the trait
- autosomal recessive disorder (so both parents have it)
8
Q
patho of sickle cell anemia
A
- partial or complete replacement of normal hgb with hgb S
- hgb in the RBCs takes on an elongated/sickle shape
- sickled cells are rigid and obstruct blood flow–>engorgement and tissue ischemia
- when hgb is deprived of O2–>hypoxia–>clumping and agglutination of the sickling cells
- hgb in the RBCs takes on an elongated/sickle shape
- dz not normally seen until 6 mos of age b/c hgb F does not sickle
- large tissue infarctions occur–>damaged tissues in organs lead to impaired fcn
9
Q
splenic sequestration
A
- occurs with sickle cell anemia
- blood pools in the spleen which can cause a splenic rupture and can look like hypovolemic shock (tachycardia, hypoTN)
- may require splenectomy at an early age
- results in dec immunity
- need prophylactic abx and MUST have immunizations
10
Q
dx of sickle cell
A
- cord blood in newborns is tested
- newborn screening is done in most states
- genetic testing is done to identify carriers and children who have dz
- sickle turbidity test: quick screening purposes in children older than 6 mos
11
Q
prognosis of sickle cell
A
- no cure (except possibly a bone marrow transplant)
- supportive care and prevent sickling episodes
- frequent bacterial infections may occur due to immunocompromise–>due to lack of splenic involvement
- bacterial infection is leading cause of death to yg kids w/ sickle cell dz
- strokes occur in children
- result in neurodevelopmental delay, cognitive disabilities
12
Q
precipitating factors of a sickle cell crisis
A
- anything that inc the body’s need for O2 or alters transport of O2
- trauma
- infection, fever
- physical and emotional stress
- inc blood viscosity due to dehydration
- hypoxia
- from high altitude, poorly pressurized airplanes, hypoventilation, vasoconstriction due to hypothermia
13
Q
vaso occlusive/thrombotic sickle cell crisis
A
- preferably called a painful event/episode
- most common type
- very painful
- stasis of blood w/ clumping of cells in microcirculation–>ischemia–>infarction
- signs: fever, pain, tissue engorgement
14
Q
splenic sequestration: sickle cell crisis
A
- life threatening–death can occur w/in hours
- blood pools in the spleen and sometimes the liver
- S/S:
- profound anemia: pallor, fatigue, low O2, tachycardia, tachypnea
- hypovolemia
- shock
15
Q
aplastic crises: sickle cell crisis
A
- diminished production and inc destruction of RBCs
- triggered by viral infection or depletion of folic acid
- S/S:
- pallor
- profound anemia: low O2, tachycardia, tachypnea
16
Q
acute chest syndrome
A
- clinically similar to pneumonia
- vaso-occlusive crisis or infection results in sickling in the lungs b/c the lungs are being deprived of adequate perfusion
- need to reverse ASAP or they die
- S/S: chest pain, fever, cough, tachypnea, wheezing, hypoxia, may have inc WOC w/ retractions
- repeated episodes may lead to pulmonary HTN and restrictive lung dz
17
Q
tx of acute chest syndrome
A
- O2 administration based on ABGs and/or pulse ox reading
- transfusion
- IS to prevent atelectasis
- pain meds
- prevent fluid overload
18
Q
psychosocial needs with Sickle Cell Anemia
A
- coping mechanisms
- support w/ genetic counseling
- financial needs
- caregiver role strain
- living with chronic illness in the family
19
Q
medical tx of SCD
A
- IV should be started immediately
- transfusion:
- prevention of stroke
- monthly transfusions to keep hgb S at only 20-30%
- risks:
- iron overload
- development of abs to foreign RBCs
- contamination w/ infective agents hyperviscosity of blood
- transfusion rxns
- time consuming
20
Q
medication to tx SCD
A
- hydroxyurea: medication that increases the formation of Hgb F b/c it doesn’t sickle
21
Q
how to tx a pt in vaso occlusive crisis
A
- fluids: usually 2x maintenance
- O2
- pain meds:
- must have opioids!
- need large doses, so should be on PCA–to prevent breakthrough pain
- demerol (meperidine) should not be used b/c the metabolites it breaks down to are toxic to CNS
- hydromorphone (dilaudid) and morphine are considered the best drugs for pain mgmt
- NSAIDs: ketorolac–is used if serum Cr is <1.5
- No ASA: may inc acidosis
- must have opioids!
22
Q
nursing mgmt of SCD
A
- monitor child’s growth–watch for failure to thrive
- careful multisystem assessment
- assess pain
- observe for presence of inflammation or possible infection
- need to tx infection promptly
- maintain hydration (oral or other as needed)
- carefully monitor for S/S of shock
23
Q
HTSC transplant
A
- human tumor stem cell (HTSC)
- potential cure for pts with SCD
- difficult decision
- child may face death w/o transplant
- preparing child for transplant places them at risk
- no “rescue” procedure if complications follow
24
Q
labs w/ hemophilia
A
- prolonged PTT
- normal PT
- normal bleeding time
- normal platelet count
- deficiency of factor VIII or IX
25
what is hemophilia
* group of hereditary bleeding disorders that result from deficiencies of specific clotting factors
26
Hemophilia A
* classic hemophilia
* deficiency of factor VIII
* most common type of hemophilia
* occurrence: 1 in 5000 males
27
Hemophilia B
* also known as Christmas Disease
* caused by deficiency in factor IX
* only 15% of cases of hemophilia
28
etiology of hemophilia A
* X linked recessive trait
* mom is carrier--\>boys are affected
* degree of bleeding depends on amount of clotting factor and severity of a given injury
* 33% have NO family hx
* dz caused by new mutation
29
manifestations of hemophilia
* bleeding tendencies range from mild to severe
* symptoms may not occur until 6 mos of age b/c not may injuries before then
* mobility leads to injuries from falls and accidents
* hemoarthrosis: bleeding into joint spaces of knee, ankle, elbow--\>leads to impaired mobility
* ecchymosis: bruising
* epistaxis
* bleeding after procedures:
* minor trauma, tooth extraction, minor surgeries
* large subQ and IM hemorrhages may occur
* bleeding into neck, chest, mouth may compromised airway
30
hemophilia clinical therapy
* can be dx thru amniocentesis
* genetic testing of family members to identify carriers
* dx on basis of hx, labs, exam
31
medical mgmt of hemophilia
* DDAVP (AKA desmopressin/vasopressin)
* IV
* causes 2-4x inc in factor VIII activity
* used for mild hemophilia
* replace missing clotting factors
* transfusions
* at home w/ prompt intervention to dec complications
* following major or minor hemorrhages
32
prognosis of hemophilia
* mild to moderate hemophilia: live near normal lives
* gene therapy for future:
* infuse carrier organisms into pt
* these act on target cells to promote manufacture of deficient clotting factors
* most often die from head injuries b/c have internal bleeding w/ no external problems
33
interventions w/ hemophilia
* close supervision and safe environment
* dental procedures in controlled situation
* shave only w/ electric razor
* superficial bleeding: apply pressure for at least 15 min and ice to vasoconstrict
* if significant bleeding occurs, transfuse for factor replacement
34
mgmt of hemoarthrosis
* during bleeding episodes, elevate and immobilize the joint
* ice--\>vasoconstrict
* analgesics--\>avoid ASA
* ROM after bleeding stops to prevent contractures--\>do active ROM
* PT
* avoid obesity to minimize joint stress